Our top pick for
Biglari Holdings Inc is a restaurants business based in the US. Biglari shares (BH) are listed on the NYSE and all prices are listed in US Dollars. Biglari employs 3,862 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$166.09|
|52-week range||$81.00 - $188.50|
|50-day moving average||$166.52|
|200-day moving average||$162.60|
|Wall St. target price||$500.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$325.56|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-21)||0.21%|
|1 month (2021-09-28)||1.21%|
|3 months (2021-07-28)||-0.16%|
|6 months (2021-04-28)||24.00%|
|1 year (2020-10-28)||93.24%|
|2 years (2019-10-28)||97.28%|
|3 years (2018-10-26)||10.64%|
|5 years (2016-10-28)||435|
Valuing Biglari stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Biglari's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Biglari's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 1x. In other words, Biglari shares trade at around 1x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Biglari's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $63.7 million.
The EBITDA is a measure of a Biglari's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$386.6 million|
|Operating margin TTM||8.79%|
|Gross profit TTM||$137 million|
|Return on assets TTM||2.21%|
|Return on equity TTM||19.08%|
|Market capitalisation||$514.5 million|
TTM: trailing 12 months
There are currently 32,971 Biglari shares held short by investors – that's known as Biglari's "short interest". This figure is 2.9% down from 33,947 last month.
There are a few different ways that this level of interest in shorting Biglari shares can be evaluated.
Biglari's "short interest ratio" (SIR) is the quantity of Biglari shares currently shorted divided by the average quantity of Biglari shares traded daily (recently around 4287.5162548765). Biglari's SIR currently stands at 7.69. In other words for every 100,000 Biglari shares traded daily on the market, roughly 7690 shares are currently held short.
However Biglari's short interest can also be evaluated against the total number of Biglari shares, or, against the total number of tradable Biglari shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Biglari's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Biglari shares in existence, roughly 10 shares are currently held short) or 0.1536% of the tradable shares (for every 100,000 tradable Biglari shares, roughly 154 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Biglari.
Find out more about how you can short Biglari stock.
We're not expecting Biglari to pay a dividend over the next 12 months.
Biglari's shares were split on a 1077:1000 basis on 14 August 2014. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1077 shares. This wouldn't directly have changed the overall worth of your Biglari shares – just the quantity. However, indirectly, the new 7.1% lower share price could have impacted the market appetite for Biglari shares which in turn could have impacted Biglari's share price.
Over the last 12 months, Biglari's shares have ranged in value from as little as $81 up to $188.5. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Biglari's is 2.2811. This would suggest that Biglari's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Biglari Holdings Inc. , through its subsidiaries, primarily operates and franchises restaurants in the United States. The company owns, operates, and franchises restaurants under the Steak n Shake and Western Sizzlin names. As of December 31, 2020, it operated 194 Steak n Shake traditional franchise and 86 franchise partner units, as well as Steak n Shake company-operated restaurants; and 3 Western Sizzlin company-operated restaurants and 39 franchised units. The company also engages in underwriting commercial trucking insurance; selling physical damage and non-trucking liability insurance to truckers; and providing property and casualty insurance. In addition, it operates oil and natural gas properties in the Gulf of Mexico; publishes and sells magazines, and related publishing products under the MAXIM and Maxim brand name; and licenses media products and services, as well as engages in the investment activities. The company was formerly known as The Steak n Shake Company and changed its name to Biglari Holdings Inc.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.